It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(visit the link for the full news article)
A large German pharmaceutical company is bringing out the heavy artillery against a Danish professor, reports Danish newspaper Berlingske.
The company, Fresenius Kabi, is threatening to lodge a compensation claim worth millions after Professor Anders Perner published a study arguing that a common treatment for severe sepsis with the drug hydroxyethyl starch (HES) can induce kidney failure and haemorrhages, which in the worst case can kill the patient
Fresenius Kabi claims that Perner’s study contains incorrect and misleading information and demands that the professor retracts the article, corrects a number of details and in a revised manuscript announces that the original article contained incorrect information.
According to the newspaper, Danish scientists are dismayed by the company’s methods, which the Danish National Hospital’s medical director Jannik Hilsted calls an attempt to suppress academic freedom.
Hilsted denies the accusations, referring to the company’s initiative as ‘bullying methods’.
I guess the interpretation of the data wil lbe a fundamental point of argument between the 2 sides & the debate will probably only be reported in industry rags like this one so will mostly go under the radar.
“This is a significantly increased risk, and the country’s intensive care units have stopped using this drug to treat sepsis.”
The results were clear: the two fluids’ ability to stabilise the circulation was identical.
As regards side effects, however, significantly more patients in the starch group developed kidney failure and required dialysis. These patients also had a greater number of haemorrhages which were so severe that the patients required blood transfusion.
“Globally, severe sepsis is the most frequent cause of death.
Dr. Perner reports receiving grant support from Fresenius Kabi. .